This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of Moderna Inc. MRNA shed 2.89% to $160.90 Tuesday, on what proved to be an all-around rough trading session for the stock market, with the NASDAQ Composite Index COMP falling 1.87% to 11,562.57 and Dow Jones Industrial Average DJIA falling 0.71% to 31,761.54. Moderna Inc. closed $336.59 below its 52-week high ($497.49), which the company reached on August 10th.
The stock underperformed when compared to some of its competitors Tuesday, as AbbVie Inc. ABBV rose 0.43% to $150.87, Amgen Inc. AMGN rose 0.97% to $251.14, and AstraZeneca PLC ADR AZN rose 0.85% to $66.72. Trading volume (2.8 M) remained 2.6 million below its 50-day average volume of 5.4 M.
Data source: Dow Jones Market Data, FactSet. Data compiled July 26, 2022.
(END) Dow Jones Newswires
July 26, 2022 16:32 ET (20:32 GMT)
Copyright (c) 2022 Dow Jones & Company, Inc.